Profile data is unavailable for this security.
About the company
Immuno-Biological Laboratories Co., Ltd. is a Japan-based company engaged in the research, development, manufacture and sales of pharmaceutical products and quasi-drugs. The Company operates in four business segments. The Diagnostic and Reagent segment is engaged in the manufacture, purchase and sales of research-related reagents, medicine, as well as vitro diagnostics. The Genetically Modified Silkworm segment is engaged in the sales of transgenic silkworm cocoons related products and research development of pharmaceutical raw materials. The Testing segment is engaged in the provision of support for prevention and diagnosis in addition to drug discovery and research support in the field of lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics segment is engaged in the sales of cosmetics and other products.
- Revenue in JPY (TTM)788.12m
- Net income in JPY-192.71m
- Incorporated1982
- Employees60.00
- LocationImmuno-Biological Laboratories Co Ltd1091-1, Naka Aza-HigashidaFUJIOKA-SHI 375-0005JapanJPN
- Phone+81 274222889
- Fax+81 274236055
- Websitehttps://www.ibl-japan.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ribomic Inc | 62.64m | -979.09m | 3.07bn | 25.00 | -- | 0.8367 | -- | 48.96 | -27.45 | -27.45 | 1.76 | 100.39 | 0.0144 | -- | 1.22 | 2,505,440.00 | -22.56 | -32.10 | -24.05 | -33.30 | -- | -- | -1,563.14 | -1,688.50 | 18.53 | -- | 0.00 | -- | -18.47 | 0.3809 | 1.88 | -- | 10.04 | -- |
| D.Western Therapeutics Institute Inc | 428.36m | -812.41m | 3.39bn | 21.00 | -- | 2.64 | -- | 7.91 | -25.45 | -25.45 | 13.48 | 39.83 | 0.1607 | 0.4389 | 2.98 | 20,398,290.00 | -31.09 | -13.06 | -33.75 | -14.36 | 91.44 | 94.29 | -193.39 | -72.51 | 10.57 | -- | 0.4089 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| OncoTherapy Science, Inc. | 901.22m | -1.19bn | 3.58bn | 60.00 | -- | 5.31 | -- | 3.97 | -5.77 | -5.77 | 4.36 | 3.01 | 0.7589 | 5.31 | 15.74 | 15,020,330.00 | -100.44 | -50.21 | -132.58 | -55.41 | -9.03 | -- | -132.35 | -331.97 | 3.29 | -258.18 | 0.00 | -- | -1.63 | 39.97 | 56.50 | -- | -57.92 | -- |
| Kringle Pharma Inc | 70.58m | -865.79m | 3.58bn | 13.00 | -- | 1.45 | -- | 50.75 | -158.59 | -158.59 | 12.88 | 374.93 | 0.024 | -- | 0.7308 | 5,428,846.00 | -29.38 | -19.00 | -30.70 | -20.23 | -- | -- | -1,226.76 | -156.51 | 26.45 | -1,190.33 | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.79bn | 57.00 | 13.40 | 2.14 | 10.39 | 2.87 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.89m | -1.49bn | 3.94bn | 12.00 | -- | 1.48 | -- | 98.80 | -26.80 | -26.80 | 0.7175 | 47.21 | 0.0107 | 0.5317 | 14.77 | 3,323,917.00 | -40.06 | -36.51 | -43.86 | -39.47 | 70.48 | -- | -3,734.55 | -13,528.87 | 10.01 | -- | 0.0512 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| BrightPath Biotherapeutics Co Ltd | 118.00k | -1.21bn | 4.04bn | 32.00 | -- | 4.78 | -- | 34,268.25 | -19.27 | -19.27 | 0.0019 | 11.92 | 0.00007 | -- | 0.0423 | 3,687.50 | -71.34 | -42.65 | -89.42 | -44.49 | -433.05 | 57.16 | -1,028,827.00 | -4,430.66 | -- | -875.45 | 0.3929 | -- | -65.73 | -56.89 | -0.0971 | -- | -56.39 | -- |
| Perseus Proteomics Inc | 96.22m | -1.12bn | 4.08bn | 24.00 | -- | 2.52 | -- | 42.40 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
| FunPep Co Ltd | 530.00k | -933.42m | 4.14bn | 15.00 | -- | 1.67 | -- | 7,802.64 | -40.11 | -40.11 | 0.0225 | 94.97 | 0.0002 | -- | -- | 35,333.33 | -34.04 | -27.10 | -35.68 | -28.75 | -- | -- | -176,116.20 | -815.82 | 25.95 | -1,765.73 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.41bn | 60.00 | -- | 4.01 | -- | 5.59 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| Renascience Inc | 191.32m | -331.66m | 4.45bn | 3.00 | -- | 2.71 | -- | 23.26 | -26.09 | -26.09 | 15.05 | 129.22 | 0.0851 | -- | -- | 63,772,000.00 | -14.74 | -- | -15.49 | -- | 85.75 | -- | -173.36 | -- | -- | -- | 0.1782 | -- | -27.84 | -- | -32.05 | -- | -- | -- |
| MEDRx Co Ltd | 29.53m | -932.90m | 4.81bn | 22.00 | -- | 2.29 | -- | 162.92 | -27.24 | -27.24 | 0.8492 | 50.17 | 0.0171 | 0.2606 | 1.22 | 1,342,455.00 | -54.07 | -58.15 | -58.45 | -62.23 | 91.87 | 95.70 | -3,158.72 | -1,526.17 | 17.75 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| Solasia Pharma KK | 617.00m | -1.11bn | 5.22bn | 24.00 | -- | 2.50 | -- | 8.47 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.25bn | 144.00 | 7.56 | 0.775 | 6.94 | 1.04 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
| Kidswell Bio Corp | 2.62bn | -1.21bn | 5.44bn | 41.00 | -- | 3.67 | -- | 2.08 | -37.72 | -37.72 | 77.56 | 37.57 | 0.5583 | 1.26 | 4.00 | 63,807,830.00 | -25.82 | -58.77 | -36.65 | -77.44 | 50.30 | 59.87 | -46.25 | -139.31 | 1.86 | -21.98 | 0.6118 | -- | 76.92 | 21.24 | -22.83 | -- | -- | -- |
| Cyfuse Biomedical KK | 61.11m | -589.21m | 5.75bn | 21.00 | -- | 1.79 | -- | 94.17 | -75.45 | -75.45 | 7.82 | 405.80 | 0.0135 | 0.5407 | 3.98 | 2,910,095.00 | -13.05 | -- | -15.34 | -- | 61.76 | -- | -964.15 | -- | 5.92 | -71.55 | 0.2218 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Immuno-Biological Laboratories Co Ltd's reporting currency: Japanese Yen JPY
